| mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
3e-06 |
| mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
6e-06 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
8e-06 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-05 |
| mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
1e-05 |
| mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-05 |
| mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-05 |
| mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
3e-05 |
| mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
4e-05 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.24 |
4e-05 |